CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZN

Capivasertib

Phase 3
AstraZeneca PLC (AZN)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Oct '26
AZNPhase 3
Positive

Capivasertib Phase 3 Est. Readout

Capivasertib
Oct 2026~
CT.gov
Competitive Landscape

1 competitor in Triple Negative Breast Neoplasms

View Full Landscape
Drug Information

Target Indication

Triple Negative Breast Neoplasms

Clinical Trial

NCT03997123

Last updated: 1/8/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.